HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 102.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,938,857 | -54.9% | 450,897 | -42.5% | 0.18% | -52.5% |
| Q2 2023 | $4,301,915 | -1.8% | 783,591 | -24.9% | 0.38% | -8.6% |
| Q1 2023 | $4,382,893 | +50.1% | 1,043,546 | -1.0% | 0.42% | +43.8% |
| Q4 2022 | $2,920,411 | -15.0% | 1,054,300 | -21.4% | 0.29% | -20.1% |
| Q3 2022 | $3,436,000 | -61.1% | 1,342,091 | -45.3% | 0.36% | -59.2% |
| Q2 2022 | $8,827,000 | -43.7% | 2,451,861 | -3.0% | 0.89% | -28.9% |
| Q1 2022 | $15,691,000 | -12.3% | 2,526,789 | -0.5% | 1.25% | +3.9% |
| Q4 2021 | $17,899,000 | +8.7% | 2,538,799 | +7.7% | 1.20% | +0.3% |
| Q3 2021 | $16,459,000 | +8.7% | 2,358,010 | +29.7% | 1.20% | +10.2% |
| Q2 2021 | $15,143,000 | +72.2% | 1,817,877 | +12.9% | 1.09% | +57.6% |
| Q1 2021 | $8,795,000 | +53.1% | 1,610,813 | +20.3% | 0.69% | +32.4% |
| Q4 2020 | $5,745,000 | +94.9% | 1,339,182 | +36.8% | 0.52% | +56.8% |
| Q3 2020 | $2,947,000 | +64.1% | 979,067 | +69.0% | 0.33% | +62.4% |
| Q2 2020 | $1,796,000 | – | 579,294 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |